Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous vitamin C in patients with COVID-19
IRCT20200411047025N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ascorbic acid in coronavirus disease 2019 (COVID-19), sponsored by Tehran University of Medical Sciences. Primary endpoints: Clinical signs and symptoms and Laboratory findings. Started Apr 2020; status: completed.
02
Drugs
ascorbic acid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200411047025N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200411047025N1.